Hi, what are you looking for?
India’s IT-giant Infosys is ramping up to its activities in Israel. The company wants to tap into Israel’s start-up ecosystem, aiming to hire talent...
Opko Health (NYSE: OPK; TASE: OPK), controlled by chairman Dr. Phillip Frost, has acquired EirGen Pharma, Ltd., a pharmaceutical company based in Ireland, focused on...
Pitney Bowes Inc. (NYSE:PBI) has acquired Borderfree (Nasdaq:BRDR), an Israeli global ecommerce solutions, for $14.00 per or $395 million. Borderfree was founded in 1999...
John Paulson's hedge fund has increased its holdings in Mylan NV to 4.5%.
The Teva shareholder and digital printing pioneer thinks Teva should be investing in innovation, not cheap commodity drugs.
New OphthaliX strategy aims to combine ophthalmic medical devices and pharmaceutical products to address multi-billion dollar markets in treating ophthalmic diseases.
Mylan's filing on executive compensation reveals much higher pay than at Teva.
[FULL LETTER] After Mylan Responded aggressively to Teva's bid, Erez Vigodman says in an open letter to Robert Coury: Shareholders won't benefit from Mud...
Mylan offered Perrigo shareholders $75 plus 2.3 Mylan shares per Perrigo share, for a total of $35.6 billion. Perrigo Company (NYSE:PRGO; TASE:PRGO) board of...
Mylan, itself the subject of a hostile takeover bid from Teva, is raising its offer for Perrigo for the second time. Mylan N.V. has...